Condition
Chronic Iron Overload
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
60%
3 of 5 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06215287CompletedPrimary
Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
NCT05440487CompletedPrimary
Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
NCT01825512Phase 3CompletedPrimary
Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients
NCT02720536Phase 3CompletedPrimary
Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation
NCT01740713Phase 2CompletedPrimary
Pharmacokinetic Study of Deferiprone in Paediatric Patients
Showing all 5 trials